Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Briggs

Showing results (271-280 of 375) with videos related to

Pageof 38
Sort By:
International Journal of Technology Assessment in Health Care|January 10, 2013
Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United KingdomAileen Murphy, Elisabeth Fenwick, William D Toff, et al.
The Journal of Clinical Investigation|October 1, 1992
Combined enzyme defect of mitochondrial fatty acid oxidationS Jackson, R S Kler, K Bartlett, et al.
BMC Medicine|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pharmacoeconomics|March 27, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Cost Effectiveness and Resource Allocation : C/E|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Respiratory Medicine|November 18, 2005
Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organizationYves M Gagnon, Adrian R Levy, Michael D Spencer, et al.
Allergy|April 25, 2006
Cost-effectiveness of asthma control: an economic appraisal of the GOAL studyA H Briggs, J Bousquet, M V Wallace, et al.
Clinical Therapeutics|March 30, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pharmacoeconomics - Open|March 28, 2025
Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in AdultsAndrew H Briggs, François-Xavier Chalet, Jacie Cooper, et al.
Pharmacoeconomics|April 21, 2015
Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further ElaborationDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pageof 38

Showing results (271-280 of 375) with videos related to

Sort By:
Pageof 38
International Journal of Technology Assessment in Health Care|January 10, 2013
Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United KingdomAileen Murphy, Elisabeth Fenwick, William D Toff, et al.
The Journal of Clinical Investigation|October 1, 1992
Combined enzyme defect of mitochondrial fatty acid oxidationS Jackson, R S Kler, K Bartlett, et al.
BMC Medicine|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pharmacoeconomics|March 27, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Cost Effectiveness and Resource Allocation : C/E|March 28, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Respiratory Medicine|November 18, 2005
Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organizationYves M Gagnon, Adrian R Levy, Michael D Spencer, et al.
Allergy|April 25, 2006
Cost-effectiveness of asthma control: an economic appraisal of the GOAL studyA H Briggs, J Bousquet, M V Wallace, et al.
Clinical Therapeutics|March 30, 2013
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pharmacoeconomics - Open|March 28, 2025
Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in AdultsAndrew H Briggs, François-Xavier Chalet, Jacie Cooper, et al.
Pharmacoeconomics|April 21, 2015
Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further ElaborationDon Husereau, Michael Drummond, Stavros Petrou, et al.
Pageof 38